Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Martin E. Swarbrick, Christopher J. Lord et al.|Nature Communications|2021Cited by 358
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2Nick Orr, U. Hamann, Melissa C. Southey et al.|Human Molecular Genetics|2015Cited by 48
Abstract P056: Polθ inhibitors elicit <i>BRCA</i>-gene synthetic lethality and target PARP inhibitor resistanceDiana Zatreanu, Christopher J. Lord, Helen M.R. Robinson et al.|Molecular Cancer Therapeutics|2021Cited by 3
Abstract 5697: Targeting PARP inhibitor resistance with Polθ inhibitorsDiana Zatreanu, Christopher J. Lord, Helen M. Robinson et al.|Cancer Research|2022Cited by 1